For Incyte’s eczema cream Opzelura, consumer complaint reveals ongoing quality woes, replacement backlog
When Gale Wild-Ebers, 62, ordered a second tube of Incyte’s topical eczema drug Opzelura in March, something appeared wrong with the product she received. Instead of ...
Continue Reading →
